Eleni Maria Varypataki

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto et al. · Nature · 2022 · 268 citations · Full text

Life Sciences, Cancer Biology, Immunology +16

Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation

Ana L Silva, Rodney Alexander Rosalia, Eleni Maria Varypataki et al. · Vaccine · 2015 · 124 citations

Life Sciences, Immunology, Immunization +16

Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles

Eleni Maria Varypataki, Ana L Silva, Christophe Barnier-Quer et al. · Journal of Controlled Release · 2016 · 107 citations

Pharmacy, Immunology, Molecular Pharmaceutics +17

Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ

Jens Pahl, Kitty M.C. Kwappenberg, Eleni Maria Varypataki et al. · Journal of Experimental & Clinical Cancer Research · 2014 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity

Eleni Maria Varypataki, Koen van der Maaden, Joke A. Bouwstra et al. · The AAPS Journal · 2014 · 94 citations

Pharmacy, Biotechnology, Immunology +17